Latest Articles
Endometrial Cancer, Sri Lanka’s Commonest Gynaecological Cancer - dailynews.lk
Endometrial Cancer, Sri Lanka’s Commonest Gynaecological Cancer dailynews.lk
Published: June 14, 2026, 7:42 p.m.
Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data - TipRanks
Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data TipRanks
Published: June 11, 2026, 4:35 p.m.
Epithelial-Mesenchymal Transitional Markers in Endometrial Carcinoma: A Review of Clinicopathological Correlation - Cureus
Epithelial-Mesenchymal Transitional Markers in Endometrial Carcinoma: A Review of Clinicopathological Correlation Cureus
Published: June 11, 2026, 8:19 a.m.
Four-Year RUBY Data Support Curative Intent With Dostarlimab in dMMR/MSI-H Endometrial Cancer - The ASCO Post
Four-Year RUBY Data Support Curative Intent With Dostarlimab in dMMR/MSI-H Endometrial Cancer The ASCO Post
Published: June 10, 2026, 4:41 p.m.
“I Dismissed It as Menopause”—One Woman’s Endometrial Cancer Story - Chatelaine
“I Dismissed It as Menopause”—One Woman’s Endometrial Cancer Story Chatelaine
Published: June 9, 2026, 7:04 p.m.
The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years - MSN
The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years MSN
Published: June 8, 2026, 8:37 p.m.
RUBY Trial Suggests Some Patients With Advanced Endometrial Cancer May Be Living Cancer-Free for Years - SurvivorNet
RUBY Trial Suggests Some Patients With Advanced Endometrial Cancer May Be Living Cancer-Free for Years SurvivorNet
Published: June 8, 2026, 8:12 p.m.
ASCO 2026: Key Highlights in Endometrial and Cervical Cancer - Medscape
ASCO 2026: Key Highlights in Endometrial and Cervical Cancer Medscape
Published: June 8, 2026, 5:28 p.m.
Mali Barbi, MD, MS, on Endometrial Cancer: Data in dMMR Disease and B7-H4 ADCs for Advanced Disease - The ASCO Post
Mali Barbi, MD, MS, on Endometrial Cancer: Data in dMMR Disease and B7-H4 ADCs for Advanced Disease The ASCO Post
Published: June 8, 2026, 4:29 p.m.
Mali Barbi: ASCO 2026 Endometrial Cancer Recap Highlights Potential Curative Signal in dMMR Subtype - Oncodaily
Mali Barbi: ASCO 2026 Endometrial Cancer Recap Highlights Potential Curative Signal in dMMR Subtype Oncodaily
Published: June 7, 2026, 6:12 a.m.
Link copied to clipboard!